# Plasma Concentrations of Amoxicillin Administered in High-doses During the First Week of Treatment (MAX-AMOX)

> **NCT04070469** · PHASE4 · COMPLETED · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 142 (actual)

## Conditions studied

- Infection, Bacterial

## Interventions

- **DRUG:** Amoxicillin

## Key facts

- **NCT ID:** NCT04070469
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-04
- **Primary completion:** 2024-12-19
- **Final completion:** 2024-12-19
- **Target enrollment:** 142 (ACTUAL)
- **Last updated:** 2025-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04070469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04070469, "Plasma Concentrations of Amoxicillin Administered in High-doses During the First Week of Treatment (MAX-AMOX)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04070469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*